OSPA NEGATIVE ELISA FOR LYME DISEASE
Not Available The objective of the overall SBIR effort is to design, demonstrate, and deliver to the AF a gaseous flow reactor capable of producing high-density flows of critical chemical species. Depending upon the results of a detailed flow analysis the reactor would be designed to support either a subsonic or a supersonic chemical iodine laser scaling experiment and demonstration at significant output power levels. The NC1/I transfer system is one of several promising advanced chemical iodine laser concepts. This concept has recently demonstrated laser gain. The next step on the critical technology path is the production of substantial flow rates of the key reactants-gaseous hydrazoic acid and chlorine atoms. During Phase I, we will evaluate several concepts generating both species and then integrate the selected concepts into an overall flow reactor design. Key small-scale hydrazoic acid experiments will also be conducted. The resulting high-density flow reactor, which can be the basis of a 100-W all-gas-phase chemical laser, will be delivered to AFRL/DELC at the completion of Phase II. Other chemical iodine laser concepts can also be explored using this reactive-flow apparatus. This enabling technology will permit the development of what may be the world's next major class of high-power lasers.
Small Business Information at Submission:
Principal Investigator:Raymond A. Koski
L-TWO DIAGNOSTICS, LLC
BOX 8175 NEW HAVEN, CT 94904
Number of Employees: